TY - JOUR
T1 - Precision, signal-to-noise ratio, and dose optimization of magnitude and phase arterial input functions in dynamic susceptibility contrast MRI
AU - Kotys, Melanie S.
AU - Akbudak, Erbil
AU - Markham, Joanne
AU - Conturo, Thomas E.
PY - 2007/3
Y1 - 2007/3
N2 - Purpose: To determine optimal conditions for precise measurement of arterial input function (AIFs) in dynamic susceptibility contrast (DSC) perfusion MRI. Materials and Methods: Magnitude-based (ΔR 2*) and phase-based (Δφ) AIFs were numerically simulated for several doses and baseline MRI noise levels [SNR(I0)]. Random noise (1000 realizations) was added to real/imaginary MRI signals (derived from an internal carotid AIF), and AIF signal, noise, and signal-to-noise ratio (SNR) were determined. The optimal dose was defined as the dose that maximizes mean AIF SNR over the first-pass (SNRmean), rather than SNR at the AIF peak (SNRpeak) because, compared to SNRpeak. doses predicted by SNRmean reduced the AIF-induced variability in cerebral blood flow (CBF) by 24% to 40%. Results: The AIF SNR is most influenced by choice of AIF signal, then optimal dosing, each with little penalty. Compared to ΔR2*. Δφ signal has 4 to 80 times the SNR over all doses and time points, and ∼10-fold SNRmean at respective optimal doses. Optimal doses induce 85% to 90% signal drop for the ΔR2* method, and 70% to 75% for Δφ, with two-fold dose errors causing ∼1.7-fold loss in SNRmean. Increases in SNR(I0) proportionally increase AIF SNR, but at a cost. Conclusion: AIF SNR is affected most by signal type, then dosing, and lastly, SNR(I0).
AB - Purpose: To determine optimal conditions for precise measurement of arterial input function (AIFs) in dynamic susceptibility contrast (DSC) perfusion MRI. Materials and Methods: Magnitude-based (ΔR 2*) and phase-based (Δφ) AIFs were numerically simulated for several doses and baseline MRI noise levels [SNR(I0)]. Random noise (1000 realizations) was added to real/imaginary MRI signals (derived from an internal carotid AIF), and AIF signal, noise, and signal-to-noise ratio (SNR) were determined. The optimal dose was defined as the dose that maximizes mean AIF SNR over the first-pass (SNRmean), rather than SNR at the AIF peak (SNRpeak) because, compared to SNRpeak. doses predicted by SNRmean reduced the AIF-induced variability in cerebral blood flow (CBF) by 24% to 40%. Results: The AIF SNR is most influenced by choice of AIF signal, then optimal dosing, each with little penalty. Compared to ΔR2*. Δφ signal has 4 to 80 times the SNR over all doses and time points, and ∼10-fold SNRmean at respective optimal doses. Optimal doses induce 85% to 90% signal drop for the ΔR2* method, and 70% to 75% for Δφ, with two-fold dose errors causing ∼1.7-fold loss in SNRmean. Increases in SNR(I0) proportionally increase AIF SNR, but at a cost. Conclusion: AIF SNR is affected most by signal type, then dosing, and lastly, SNR(I0).
UR - http://www.scopus.com/inward/record.url?scp=33847633445&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33847633445&partnerID=8YFLogxK
U2 - 10.1002/jmri.20859
DO - 10.1002/jmri.20859
M3 - Article
C2 - 17326084
AN - SCOPUS:33847633445
SN - 1053-1807
VL - 25
SP - 598
EP - 611
JO - Journal of Magnetic Resonance Imaging
JF - Journal of Magnetic Resonance Imaging
IS - 3
ER -